Florida Cancer Specialists & Research Institute appointed five members to its senior management team.
Florida Cancer Specialists & Research Institute, LLC has been awarded two grants by the Florida Cancer Innovation Fund.
Florida Cancer Specialists & Research Institute appoints five members to senior management
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
One year after the Centers for Medicare & Medicaid Services made the decision to pay for patient navigation services, data from early adopters show that navigation services are leading to better outcomes, significant cost savings for healthcare systems, and mitigation of health inequities.
PatientPoint, a digital health company, launched an interactive, in-office digital hub that delivers specialty-specific, customizable content and practice tools for clinicians, and allows for streamlined workflows, and enhanced collaboration across care teams.
McKesson Corp. has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures LLC (Core Ventures).
A partnership between Florida Cancer Specialists & Research Institute and Paradigm Health Inc. will provide patients in Florida with more access to new treatment options through participation in clinical trials.
Bradley Monk was named medical director of late-phase clinical research at Florida Cancer Specialists & Research Institute, LLC. Monks plans to leverage his experience and leadership across all tumor types as FCS expands in footprint in late-phase practice changing clinical trials.
